Who Owns SBIO?

ALPS Medical Breakthroughs ETF — Institutional Ownership & 13F Holdings

$54.20

-0.39 (-0.71%)

Market Cap

$137.2M

Shares Outstanding

2,500,147

Institutional Holders

35

Total Inst. Value

$40.2M

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

7

Closed Positions

7

Increased

3

Decreased

13

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1DAVENPORT & Co LLC$21.3M748,122
2BANK OF AMERICA CORP /DE/$4.0M139,699
3WELLS FARGO & COMPANY/MN$3.7M128,160
4MORGAN STANLEY$1.9M65,222
5UBS Group AG$1.6M55,432
6GWN SECURITIES INC.New$1.5M55,500
7JONES FINANCIAL COMPANIES LLLPNew$875K27,429
8GRIFFIN ASSET MANAGEMENT, INC.$859K30,135
9Phoenix Wealth AdvisorsNew$753K26,418
10GTS SECURITIES LLC$710K24,888

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-32K$1.9M
DAVENPORT & Co LLC-21K$21.3M
GTS SECURITIES LLC-17K$710K
UBS Group AG-14K$1.6M
LPL Financial LLC-5K$617K

Related Stocks

Frequently Asked Questions

How many institutional investors hold SBIO?

As of Q1 2025, 35 institutional investors report holding SBIO (ALPS Medical Breakthroughs ETF) in their 13F filings.

Which hedge fund owns the most SBIO?

The largest institutional holder of SBIO is DAVENPORT & Co LLC with $21.3M in shares.

Are institutions buying or selling SBIO?

This quarter, 7 institutions opened new positions in SBIO and 7 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.